[HTML][HTML] Tumor markers for hepatocellular carcinoma
YJ Zhao, Q Ju, GC Li - Molecular and clinical oncology, 2013 - spandidos-publications.com
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high
rate of morbidity and mortality. HCC affects approximately one million individuals annually …
rate of morbidity and mortality. HCC affects approximately one million individuals annually …
New perspectives and strategy research biomarkers for hepatocellular carcinoma
R Saffroy, P Pham, M Reffas, M Takka, A Lemoine… - 2007 - degruyter.com
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Cirrhosis
caused by hepatitis B virus, hepatitis C virus or chronic alcohol intake is associated with …
caused by hepatitis B virus, hepatitis C virus or chronic alcohol intake is associated with …
[HTML][HTML] Serum tumor markers for detection of hepatocellular carcinoma
L Zhou, J Liu, F Luo - World journal of gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the most frequent malignant tumors and is the
second most common cause of cancer death in China. Therefore, it is very important to …
second most common cause of cancer death in China. Therefore, it is very important to …
[HTML][HTML] Present and future possibilities for early diagnosis of hepatocellular carcinoma
P Stefaniuk, J Cianciara… - World journal of …, 2010 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) represents the fifth most common cancer in the world, and
the third most frequent oncological cause of death. The incidence of HCC is on the increase …
the third most frequent oncological cause of death. The incidence of HCC is on the increase …
Biomarkers for hepatocellular carcinoma
T Behne, MS Copur - International journal of hepatology, 2012 - Wiley Online Library
The hepatocellular carcinoma (HCC) is one of the most common malignant tumors and
carries a poor survival rate. The management of patients at risk for developing HCC remains …
carries a poor survival rate. The management of patients at risk for developing HCC remains …
New frontiers in biomarkers for hepatocellular carcinoma
G Giannelli, S Antonaci - Digestive and Liver disease, 2006 - Elsevier
Hepatocellular carcinoma represents the fifth most frequent cancer in the world; it commonly
occurs on cirrhotic liver. Prognosis and survival are still poor, mainly because of diagnosis at …
occurs on cirrhotic liver. Prognosis and survival are still poor, mainly because of diagnosis at …
Hepatocellular carcinoma tumour markers: current role and expectations
Tumour markers could be helpful along the continuum of care for patients with
hepatocellular carcinoma; however, there is insufficient data for routine use of most current …
hepatocellular carcinoma; however, there is insufficient data for routine use of most current …
Biology of hepatocellular carcinoma
RWC Pang, JW Joh, PJ Johnson, M Monden… - Annals of surgical …, 2008 - Springer
Hepatocellular carcinoma (HCC) is a common cancer in the world due to high prevalence of
hepatitis B or C virus infection. Research in recent years has uncovered important molecular …
hepatitis B or C virus infection. Research in recent years has uncovered important molecular …
Newer markers for hepatocellular carcinoma
JA Marrero, ASF Lok - Gastroenterology, 2004 - Elsevier
The incidence of hepatocellular carcinoma (HCC) is increasing worldwide; the overall
survival of patients with HCC is grim because most patients are diagnosed late, when …
survival of patients with HCC is grim because most patients are diagnosed late, when …
[HTML][HTML] Emerging biomarkers in HCC patients: Current status
HP Marques, SG da Silva, E De Martin… - International Journal of …, 2020 - Elsevier
Hepatocellular carcinoma (HCC) is the liver's most common primary malignancy, with over
half a million new cases diagnosed each year and being the fourth leading cause of cancer …
half a million new cases diagnosed each year and being the fourth leading cause of cancer …